Open letter to Lamberto Andreotti, Chief Executive Officer, Bristol-Myers Squibb

The Lancet

Volumn 375, Issue 9733, 2010, Pages 2213-

  Kamal Yanni, Mohga ^a   Nichols, Kim ^b   Tallah, Esther ^c   Otwoma, Nelson ^d  

^a Oxfam GB ^*  (United Kingdom)

^b African Services Committee   (United States)

^c Cameroon Coalition Against Malaria   (Cameroon)

^d National Empowerment Network of People Living with HIV/AIDS in Kenya   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE;

DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; FRANCE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MEDICAL RESEARCH; PATIENT CARE; PRIORITY JOURNAL; STANDARD;

EID: 77953870863     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60940-3     Document Type: Letter

References (0)